Yokohama, Japan

Junko Watanabe

This inventor holds 3 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1994-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junko Watanabe. Retrieved from https://idiyas.com/inventor/junko-watanabe-hwekklgk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1994-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Junko Watanabe: Innovator in DNA Gyrase Inhibitors

Introduction

Junko Watanabe is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of DNA gyrase inhibitors. With a total of three patents to her name, Watanabe's work has the potential to impact medical treatments significantly.

Latest Patents

Watanabe's latest patents include a process for the preparation of DNA gyrase inhibitors, specifically focusing on bicyclic derivatives of a general formula. These compounds are designed to be useful in the preparation of DNA gyrase inhibitors, showcasing her innovative approach to pharmaceutical development. The detailed specifications of her patents highlight the complexity and potential applications of her work in the medical field.

Career Highlights

Watanabe is currently employed at Hoffmann-La Roche Inc., where she continues to advance her research and development efforts. Her career is marked by a commitment to innovation and excellence in the pharmaceutical industry.

Collaborations

Throughout her career, Watanabe has collaborated with notable colleagues, including Mikio Arisawa and Erwin Gotschi. These partnerships have likely contributed to her success and the advancement of her research.

Conclusion

Junko Watanabe is a trailblazer in the field of DNA gyrase inhibitors, with a strong portfolio of patents and a commitment to innovation. Her work at Hoffmann-La Roche Inc. and collaborations with esteemed colleagues further underscore her impact on the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…